Search results for: 'computing power'

08 Apr 2015  |  Asia Pacific  |  Market Research

Analysis of the TIM (Thailand, Indonesia, and Malaysia) Digital and Computed Radiography Markets

Technology Enhancements Accelerate Growth of X-ray Imaging

Infographics

×

This research service presents an analysis of the digital and computed radiography markets in Thailand, Malaysia, and Indonesia (TIM). It provides an in-depth analysis of the current trends and market size, as well as regional market drivers and restraints. The study offers revenue forecasts by country and discusses market penetration and market at...

The impressive advances in life sciences research and development (R&D) befallen in the past two-three years are playing a leading role in the transformation of the healthcare industry. A myriad of new developments in the fields of gene and cell therapies, empowered with nanotechnology advances, omics technologies and novel smart molecules approach...

Vaccines represent a class of biologics that are administered to prevent infectious diseases to reduce mortality and morbidity. It is estimated that the introduction of vaccines has reduced the incidence of various diseases by greater than 90%. This study examines the global vaccines market, including marketed products and products under clinical d...

03 Feb 2021  |  North America  |  Market Research

Companion Diagnostics (CDx) is Revolutionizing the Global Clinical Next-generation Sequencing (NGS) Market

Next-generation Blockchain-Powered Genomic Data Marketplaces are Creating New Growth Opportunities

Infographics

×

2020 will be remembered for the COVID-19 pandemic, masks, social distancing protocol, alternate care sites, Moderna, Pfizer, BioNTech, AstraZeneca, RT-PCR, and serology testing (or all the above). However, in the midst of our response to the global pandemic, remarkable advancements were made in another great frontier in medicine that remains unconq...

12 Aug 2020  |  North America  |  Market Research

New Drug Development for Rare Pediatric Disorders Sustaining High Growth in the Global Orphan Drugs Market, 2019–2025

AI-powered Early Disease Diagnosis and Drug Repurposing will Create New Growth Opportunities

Infographics

×

Key Issues Addressed

Rare diseases have been an increasing area of focus as three waves have converged in recent years: genomic research and innovations becoming mainstream; the forthcoming regulatory policies and financial incentives put in place by the federal agencies; and the increasingly patient-centric and coordinated efforts of patient advocacy groups, caregive...

24 Aug 2021  |  North America  |  Market Research

US and EU Biotech Industry VC Investment Growth Opportunities

Future Growth Potential Driven by Next-generation Cell and Gene Platform Technology Powered by AI

Infographics

×

With this research service, Frost & Sullivan provides critical insights into the biotech, and cell and gene therapy (CGT) venture capital (VC) investment trends highlighting the growth opportunities, key countries in the VC environment, and major trends in cell and gene therapy segment. The study also identifies actionable growth opportunities for ...

The Singapore private outpatient diagnostic imaging services market offers insights on diagnostic imaging products such as computed tomography scanners, magnetic resonance imaging, X-ray, mammogram, positron emission tomography, and single-photon emission computed tomography used in polyclinics, private hospitals, and diagnostic centers. Procedura...

15 Dec 2015  |  Asia Pacific  |  Market Research

Analysis of the Medical Imaging Market in Selected ASEAN Countries

Growth and Trends in CT, MR, PET, and SPECT Modalities

Infographics

×

This research service provides an analysis of the medical imaging market in Indonesia, Malaysia, Singapore, and Thailand. It provides a detailed analysis of current trends, market size, revenue forecasts, and drivers and restraints for the computed tomography (CT), medical resonance (MR), Positron emission tomography (PET), and single-photon emissi...

Pharmaceutical drug discovery and development suffers from declining success rates with new molecules, and the rate of return has shrunk from 16% in 2011 to almost 11% in 2018. Frost & Sullivan finds that traditional solutions focused primarily on data from limited sources and rule-based computational techniques used to address the understanding of...